Dr. Robert E Lynch , MD
Specialist β’ Tulsa, OK
9228 S Mingo Rd, Suite 200
Tulsa, OK 741335718
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on January 26, 2006; this date does not establish years in practice.
-
Published CMS data list 136 Medicare Part D prescriptions, including refills, in 2017.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2017. Published rows only; this is not a quality measure.
-
Published Part D records, 2017:
- Atorvastatin Calcium β 30 prescription fills, including refills.
- Lisinopril β 26 prescription fills, including refills.
- Amlodipine Besylate β 20 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2017. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 7 records in the table Β· Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 194 in 2013 to 136 in 2017.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2013β2017.
Practice Location & Contact Primary Location
9228 S Mingo Rd
Suite 200
Tulsa, OK 741335718
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Specialist: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
283 standardized 30-day fills in 2017
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$1,485 in 2017
The total cost of these prescriptions in 2017, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers β by Provider and Drug, 2017.
Industry payments (Open Payments)
Fewer than 11 payment records totaling $18.32 in 2020
Drug and medical device companies must report certain payments to doctors and some other clinicians to CMS, such as meals, travel, speaking fees or research funding.
It shows reported financial ties between this clinician and companies. You can ask your clinician about them.
These records are submitted by drug and medical device companies, and a reported payment does not necessarily mean the financial relationship is improper.
General: payments not tied to research, such as meals, travel, consulting or speaking fees.
A reported payment does not necessarily mean the financial relationship is improper. Research payments can go to a hospital or university for a study the clinician leads, not to the clinician personally. Clinicians can dispute records with the company that reported them.
Source: CMS Open Payments, program year 2020.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, βDoes your provider accept Medicare as full payment?β
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Lynch has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Lynch as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Tulsa and Oklahoma
Billing and prescribing volume is not a quality rating.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Lynch are from 2017.
72 active clinicians are listed under Specialist with a practice address in Tulsa, OK (425 in Oklahoma).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Tulsa
2.8% of these 72 clinicians have the CMS telehealth indicator.
6.9% of these 72 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 30% from 194 in 2013 to 136 in 2017.
- 2013: 194
- 2014: 257
- 2015: 378
- 2016: 444
- 2017: 136
-
30-day fills
30-day fills increased 19% from 238 in 2013 to 283 in 2017.
- 2013: 238
- 2014: 371
- 2015: 609
- 2016: 754
- 2017: 283
-
Part D drug cost
Part D drug cost decreased 88% from $12,154 in 2013 to $1,485 in 2017.
- 2013: $12,154
- 2014: $10,253
- 2015: $14,040
- 2016: $20,800
- 2017: $1,485
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $18.25 in 2019 to $18.32 in 2020.
- 2019: $18.25
- 2020: $18.32
Sources: CMS Medicare Part D Prescribers (2017), CMS Open Payments (2020), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo Β· Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2020 (payments made January 1 β December 31, 2020): fewer than 11 records totaling $18.32.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
CHANTIX | General | $18.32 |
Source: CMS Open Payments, program year 2020, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2017.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 30 | 2,444 | $552.99 | 16 |
| Lisinopril | Lisinopril | 26 | 1,797 | $220.73 | β |
| Amlodipine Besylate | Amlodipine Besylate | 20 | 1,080 | $126.88 | β |
| Furosemide | Furosemide | 19 | 908 | $126.68 | β |
| Metoprolol Succinate | Metoprolol Succinate | 15 | 750 | $269.94 | β |
| Clopidogrel | Clopidogrel Bisulfate | 13 | 870 | $124.58 | β |
| Losartan Potassium | Losartan Potassium | 13 | 630 | $63.08 | β |
Source: CMS Part D by Provider and Drug, 2017; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 174400000X
An individual educated and trained in an applied knowledge discipline used in the performance of work at a level requiring knowledge and skills beyond or apart from that provided by a general education or liberal arts degree.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - CARDIOVASCULAR DISEASE (CARDIOLOGY)
I20080716000238
OK
2769555333
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Endocrinology, Diabetes & Metabolism
Doctor of Medicine (M.D.)
Internal Medicine - Clinical Cardiac Electrophysiology
Internal Medicine - Cardiovascular Disease
Doctor of Medicine (M.D.)
Internal Medicine - Interventional Cardiology
Doctor of Medicine (M.D.)
Internal Medicine - Cardiovascular Disease
Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.)
Internal Medicine - Cardiovascular Disease
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated January 26, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Specialists in Tulsa
- Dr. Kyle Mangels, MD
- Dr. Frank Tomecek, MD
- Dr. Ajay Bedekar, MD
- Dr. Christopher Covington, MD
- Dr. Kayla Unruh, DPT
- Dr. John Thompson, MD
Mailing Address
9228 S Mingo Rd, Suite 200
Tulsa, OK 741335718
Phone: 9185920999